Cargando…
Biological determinants of health disparities in multiple myeloma
Multiple myeloma is a rare plasma cell cancer, and incidence rates among patients of African descent are about twice those among patients of European descent. Rates of multiple myeloma vary among different populations, but the reasons for the racial disparities in multiple myeloma are largely unknow...
Autores principales: | Smith, Cheryl Jacobs, Ambs, Stefan, Landgren, Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127236/ https://www.ncbi.nlm.nih.gov/pubmed/30190459 http://dx.doi.org/10.1038/s41408-018-0118-z |
Ejemplares similares
-
Management of multiple myeloma during COVID-19 pandemic
por: Jethava, YS, et al.
Publicado: (2020) -
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019) -
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
por: Landgren, Ola, et al.
Publicado: (2023) -
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
por: Kazandjian, Dickran, et al.
Publicado: (2019) -
Dissecting racial disparities in multiple myeloma
por: Marinac, Catherine R., et al.
Publicado: (2020)